Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View

Biotech firm Kiniksa is a standout with its profitability. The biotech stock is moving toward a buy zone amid a winning streak.

Raccontata dainvestors.com